In pancreatic ductal adenocarcinoma (PDAC), elevated WNT7B and WNT10A correlate with aggressive, basal-like disease and poor patient survival, but the mechanisms underlying this association remain unclear. This evidence concerns the gene WNT7B and pancreatic ductal adenocarcinoma.